Second Annual Biopharma Comms Forum

Few roles in biopharma demand the cross-functional range, executive judgment, and communication precision that define both a senior communications leader and a Chief of Staff. As communications leaders increasingly operate at the center of enterprise decisions, a growing number are stepping into this role formally, becoming the connective tissue between leadership intent and organizational execution in one of the most demanding environments in business.

As the boundaries of corporate affairs continue to expand, the most forward-thinking leaders in our profession are finding that the skills we have spent years building, fluency in science, finance, and strategy, the ability to read a room, translate complexity, and counsel leadership under pressure, are exactly the capabilities that define the most effective Chiefs of Staff in the industry.

This keynote examines what it actually takes to operate at the center of an organization’s most critical decisions, why communicators are positioned to do it better than almost anyone else, and what the evolution of the Chief of Staff role signals about where corporate affairs is headed next.

Establishing trust in life sciences is the operating foundation that determines whether everything else we do as communicators lands or falls flat. We are building credibility systems across external audiences and inside our own organizations simultaneously, managing the gap between how the industry sees itself and how patients, regulators, investors, and the public actually experience it. The conditions have never been more layered: misinformation moves faster than facts, AI-generated content blurs what is real, and internal influence can dissolve overnight when leadership changes or restructuring hits without warning. This panel opens a conversation about how senior corporate affairs leaders develop and protect the dual competency required right now of rebuilding credibility externally when science meets skepticism, and building influence internally that has staying power even when you’re not in the room.

Key Takeaways:

• Examine how to establish genuine authority with boards and C-suite leaders, moving beyond access to actively shaping how trust-critical decisions get made before a crisis forces the conversation.
• Map the trust gaps between your clients’/organization’s current positioning and how patients, regulators, and the public actually perceive it, and develop a proactive strategy rather than a reactive one.
• Strengthen the internal political capital that keeps communications central when organizations restructure, champions leave, and budget conversations come for your function first.
• Consider how the role of communicators is expanding from managing defined stakeholder groups to actively shaping broader public understanding of science and the industry, and what that means for how we lead.

Speaker:

• Karla MacDonald, Chief Corporate Affairs Officer, Entrada Therapeutics
• Marisol Mendez Peron, Senior Vice President, Communications & Corporate Affairs,
  Genmab
• Laure Park, Founder, ParkEdge Consulting

Built for the realities of life sciences communications, T2B’s inaugural AI in Biopharma Communications survey examines how adoption is actually taking shape across workflows, teams, and roles, from early experimentation to deeper integration within our profession. Developed through the T2B AI Roundtable with  Knowledge Partner Syneos Health Communications, the survey also looks at where formal policy and day-to-day behavior diverge. The findings shed light on how expectations for the life science communicator’s role are shifting across in-house teams, agencies, and independent consultants. Forum attendees get the first public look at the findings, along with additional insights and bonus content available only in the room.

Key Takeaways:

• See the first public benchmark data on how AI adoption is actually showing up across biopharma communications roles and work environments, and where life sciences diverges from broader industry trends.
• Understand how communicators are moving along the adoption spectrum, from early experimentation to workflow integration and more advanced use.
• Discover where policy, governance, and approved tools align with reality, and where shadow use, access gaps, or inconsistent enforcement may be shaping behavior beneath the surface.
• Explore what the data suggests about how the communicator’s role is evolving, including shifts in skills, influence, cross-functional collaboration, and expectations at different levels of seniority.
• Walk away with specific data points you can use immediately in conversations with leadership about AI governance, training investment, resourcing, and the future of the function.

Presenters:

• • Ryan Flinn, Writer/Communicator, In Like Flinn Communications
  • Eve Siegel, Head of Research & Analytics, Syneos Health Communications

AI may be able to accelerate more work than most organizations are currently using it for, but the gap between theoretical capability and real-world deployment remains wide. In Anthropic’s latest labor market research, actual usage trails far behind what large language models could theoretically do, especially in fields like ours where verification, accountability, and trust still matter deeply. For communicators, that gap is where the conversation gets interesting. The communications work that carries the most weight includes knowing when to push back on a CEO, building trust with stakeholders over years, and translating complexity in ways that require human context. This panel looks at how AI is redefining our work, which capabilities and skills are becoming more valuable as adoption spreads, and what that means for how we lead, advise, and position ourselves going forward.

Key Takeaways:

• Identify which parts of the communications role are most likely to be compressed, accelerated, or delegated to AI, and which become more valuable when scrutiny, complexity, and stakes rise.
• Strengthen the case for communications as a judgment-based function, especially when leadership is tempted to equate faster content production with stronger strategic counsel.
• Guide your team through the shift from tactical output to strategic counsel, helping them reframe their contribution around interpretation, influence, trust, and decision support.
• Sharpen your ability to read executive dynamics and advise leadership in moments where context, instinct, and relationship history are the deciding factors.
• Consider what this means for junior talent development at a moment when some evidence suggests hiring may be softening in more AI-exposed roles.

Speaker:

• • Nicole Fichera, Executive Director, Principal Consultant, Hourglass Collaborative
  • Kerry Ryan, M.S., Director, Global Executive Communications and Data, Digital & Technology Business Partner, Takeda

Presenter:

• • Tracy Sorrentino, Vice President, Corporate Affairs, Sarepta Therapeutics

As part of the Forum’s commitment to candid, practical dialogue, attendees will join one small-group breakout session designed to foster real-world knowledge-sharing. Each group will explore a distinct facet of the modern biopharma communicator’s role. Attendees can choose the topic most relevant to their interests and join a 30-minute discussion led by a peer facilitator, with guided prompts to spark conversation and connection.

Biopharma communicators are being asked to deliver more, with less, and the gap keeps widening. According to Meltwater’s State of PR 2026 report, 24% of PR and communications professionals cite insufficient resources as their top challenge, and 69% do not expect their budgets to increase in 2026. The pressure to optimize can quietly erode quality and capacity, and from the inside it can look a lot like extraction. Knowing the difference matters for our teams, our influence, and our ability to show up clearly when it counts. The cost of under-resourcing is often felt long before it is acknowledged. This panel takes a candid look at what strong communications leadership actually requires when capacity is limited and expectations stay high. We’ll talk about how to make smarter decisions about where communications should lead, where work can be shared or streamlined, and how to recognize when “efficiency” is masking real risk to teams, priorities, and business outcomes.

Key Takeaways:

• Evaluate whether your current staffing mix, agency relationships, and tools are actually earning their keep, where AI and automation can take work off your plate without sacrificing quality or strategic oversight, and where the current model is simply helping the organization postpone harder resourcing decisions.
• Distinguish between healthy efficiency and patterns of overextension that quietly erode quality, relationships, and strategic output.
• Identify where cross-functional partners can genuinely share the communications load and how to structure those working relationships so collaboration reduces pressure without creating new coordination overhead.
• Strengthen your ability to talk with leadership about capacity in business terms, including risk, decision quality, speed, stakeholder confidence, and team sustainability.
• Recognize the early signs that a lean model is no longer strategic and what it takes to reset expectations before burnout or performance erosion sets in.

Speakers:

• • David Murdoch, Director of Corporate Communications, Social Media and Executive Visibility Lead, Sumitomo Pharma America
  • Georgina Vincent, Executive Director, Communications, Charles River Laboratories
  • Tracy Vineis, Vice President, Communications, Apellis

Speaker: Lynnea Olivarez, Founder, Ticket to Biotech

Clarity is rarely lost all at once. It erodes — decision by decision, compromise by compromise — inside systems that reward reaction over reflection and performance over presence. Drawing on behavioral science, organizational research, and the lessons learned building a cross-functional biopharma communications community through one of the industry’s most volatile stretches, this session examines what clarity is actually made of, why it breaks down under sustained pressure, and how to deliberately rebuild it. We’ll move through the neuroscience of stress-impaired judgment, the research on professional identity fracture, the data on how network isolation narrows cognition, and arrive at a practical architecture for stabilizing influence when the ground keeps shifting.

Key Takeaways:

• Recognize the specific mechanisms that erode clarity under sustained organizational pressure
• Anchor decisions to values that function as real-time filters, not aspirational statements
• Cultivate curiosity as a discipline that expands perspective precisely when environments contract it
• Build community that functions as cognitive infrastructure
• Protect judgment from the structural forces most likely to compromise it